Ljungman, Charlotta E.A.
Sahlgrenska University Hospital · University of Gothenburg
7 papers on CoChatORCID 0000-0002-2785-1919
Most cited papers
- Verified
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 7,140
- Verified
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Petrie, M. C., Verma, S., Docherty, K. F., Inzucchi, S. E., Anand, I., Belohlávek, J., Böhm, M., Chiang, C.-E., Chopra, V. K., de Boer, R. A., et al. (2020) · JAMA
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 531
- Verified
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
Jackson, A. M., Dewan, P., Anand, I. S., Bělohlávek, J., Bengtsson, O., de Boer, R. A., Böhm, M., Boulton, D. W., Chopra, V. K., DeMets, D. L., et al. (2020) · Circulation
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 175
- Verified
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Serenelli, M., Böhm, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., et al. (2020) · European Heart Journal
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 138
- Verified
Exercise blood pressure and the risk of future hypertension
Holmqvist, L., Mortensen, L., Kanckos, C., Ljungman, C., Mehlig, K., & Manhem, K. (2012) · Journal of Human Hypertension
Blood Pressure and Hypertension StudiesCardiovascular and exercise physiology
Cited by 56
- Verified
Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy
Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., et al. (2020) · Diabetes Care
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 44
- Verified
Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database
Mourtzinis, G., Manhem, K., Kahan, T., Schiöler, L., Isufi, J., Ljungman, C., Andersson, T., & Hjerpe, P. (2021) · Scandinavian Journal of Primary Health Care
Blood Pressure and Hypertension StudiesHealth disparities and outcomes
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free